{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:18:31Z","timestamp":1792657111448,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1124\/jpet.118.252064","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T14:11:17Z","timestamp":1541513477000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9503-8786","authenticated-orcid":false,"given":"Jacopo","family":"Lucchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fracasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Passoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-3914","authenticated-orcid":false,"given":"Gianluigi","family":"Forloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-9873","authenticated-orcid":false,"given":"Mario","family":"Salmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-6225","authenticated-orcid":false,"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.252064_bib1","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/jps.2600641121","article-title":"Enterohepatic circulation of tetracycline in rats","volume":"64","author":"Adir","year":"1975","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.252064_bib2","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0600554103","article-title":"Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations","volume":"103","author":"Alano","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.252064_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","article-title":"Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer\u2019s disease","volume":"60","author":"Balducci","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1124\/jpet.118.252064_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1124\/jpet.118.252064_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.8.6.713","article-title":"Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs","volume":"8","author":"Barza","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.252064_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4269\/ajtmh.2009.09-0214","article-title":"Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects","volume":"81","author":"Binh","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/jpet.118.252064_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-4347(00)84428-X","article-title":"Analysis and quantitation of a metabolite of doxycycline in mice, rats, and humans by high-performance liquid chromatography","volume":"274","author":"B\u00f6cker","year":"1983","journal-title":"J Chromatogr A"},{"key":"10.1124\/jpet.118.252064_bib8","first-page":"2116","article-title":"Comparison of distribution of doxycycline in mice after oral and intravenous application measured by a high-performance liquid chromatographic method","volume":"31","author":"B\u00f6cker","year":"1981","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.118.252064_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01062336","article-title":"Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics","volume":"10","author":"Boxenbaum","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/jpet.118.252064_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1096\/fj.02-0764com","article-title":"4\u2032-iodo-4\u2032-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters","volume":"17","author":"Cardoso","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/jpet.118.252064_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model","volume":"20","author":"Cardoso","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/jpet.118.252064_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/jpet.118.252064_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1124\/jpet.118.252064_bib14","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.neuroimage.2009.03.083","article-title":"Measurement of cerebral blood volume in mouse brain regions using micro-computed tomography","volume":"47","author":"Chugh","year":"2009","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.118.252064_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1570-0232(03)00247-2","article-title":"Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat","volume":"791","author":"Colovic","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/jpet.118.252064_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007691-198206000-00001","article-title":"Doxycycline","volume":"4","author":"Cunha","year":"1982","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.118.252064_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2460\/ajvr.67.2.310","article-title":"Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses","volume":"67","author":"Davis","year":"2006","journal-title":"Am J Vet Res"},{"key":"10.1124\/jpet.118.252064_bib18","doi-asserted-by":"crossref","first-page":"e1888","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.252064_bib19","doi-asserted-by":"crossref","first-page":"15902","DOI":"10.1038\/srep15902","article-title":"Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria","volume":"5","author":"De Luigi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.118.252064_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.nbd.2010.07.002","article-title":"Tetracycline and its analogues protect Caenorhabditis elegans from \u03b2 amyloid-induced toxicity by targeting oligomers","volume":"40","author":"Diomede","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.118.252064_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/AAC.33.7.1078","article-title":"Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis","volume":"33","author":"Dotevall","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.252064_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF01926763","article-title":"Circadian rhythm in cerebral blood volume of mouse","volume":"29","author":"Edvinsson","year":"1973","journal-title":"Experientia"},{"key":"10.1124\/jpet.118.252064_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000220439","article-title":"Distribution and excretion of doxycycline in man","volume":"11","author":"Fabre","year":"1966","journal-title":"Chemotherapy"},{"key":"10.1124\/jpet.118.252064_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.118.252064_bib25","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.252064_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19336896.2015.1027857","article-title":"Preventive study in subjects at risk of fatal familial insomnia: innovative approach to rare diseases","volume":"9","author":"Forloni","year":"2015","journal-title":"Prion"},{"key":"10.1124\/jpet.118.252064_bib27","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1074\/jbc.M110.178376","article-title":"Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils","volume":"286","author":"Giorgetti","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.252064_bib28","doi-asserted-by":"crossref","first-page":"41755","DOI":"10.1038\/srep41755","article-title":"Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species","volume":"7","author":"Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.118.252064_bib29","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/jpet.118.252064_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.118.252064_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.118.252064_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1742-2094-8-152","article-title":"Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid \u03b2","volume":"8","author":"Kauppinen","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1124\/jpet.118.252064_bib33","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.4049\/jimmunol.174.4.2288","article-title":"Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death","volume":"174","author":"Kauppinen","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/jpet.118.252064_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease","volume":"52","author":"Loeb","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1124\/jpet.118.252064_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000238249","article-title":"Bioavailability of doxycycline monohydrate. A comparison with equivalent doses of doxycycline hydrochloride","volume":"30","author":"Malmborg","year":"1984","journal-title":"Chemotherapy"},{"key":"10.1124\/jpet.118.252064_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0893-133X(00)00171-8","article-title":"Caveat emptor: editors beware","volume":"24","author":"McCann","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.252064_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0160-5402(78)90054-2","article-title":"Estimation of blood content in the mouse brain by measurement of iron","volume":"1","author":"Modak","year":"1978","journal-title":"J Pharmacol Methods"},{"key":"10.1124\/jpet.118.252064_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/gps.3846","article-title":"A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer\u2019s disease: the DARAD trial","volume":"28","author":"Molloy","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1124\/jpet.118.252064_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/13506129.2013.803463","article-title":"Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis","volume":"20","author":"Montagna","year":"2013","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"10.1124\/jpet.118.252064_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/13506129.2012.678508","article-title":"Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study","volume":"19","author":"Obici","year":"2012","journal-title":"Amyloid"},{"key":"10.1124\/jpet.118.252064_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jps.2600690224","article-title":"Pharmacokinetics of doxycycline reabsorption","volume":"69","author":"Pedersen","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.252064_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2885.1989.tb00668.x","article-title":"Doxycycline binding to plasma albumin of several species","volume":"12","author":"Riond","year":"1989","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1124\/jpet.118.252064_bib43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2460\/ajvr.1990.51.08.1271","article-title":"Pharmacokinetics and metabolic inertness of doxycycline in young pigs","volume":"51","author":"Riond","year":"1990","journal-title":"Am J Vet Res"},{"key":"10.1124\/jpet.118.252064_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2885.1990.tb00797.x","article-title":"Comparative pharmacokinetics of doxycycline in cats and dogs","volume":"13","author":"Riond","year":"1990","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1124\/jpet.118.252064_bib45","series-title":"Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications","author":"Rowland","year":"2011"},{"key":"10.1124\/jpet.118.252064_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.118.252064_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000220836","article-title":"The disposition of doxycycline by the rat","volume":"17","author":"Schach won Wittenau","year":"1972","journal-title":"Chemotherapy"},{"key":"10.1124\/jpet.118.252064_bib48","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/jm400161p","article-title":"A new face for old antibiotics: tetracyclines in treatment of amyloidoses","volume":"56","author":"Stoilova","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.252064_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2885.2004.00600.x","article-title":"Plasma terminal half-life","volume":"27","author":"Toutain","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1124\/jpet.118.252064_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","article-title":"Doxycycline in early CJD: a double-blinded randomised phase II and observational study","volume":"88","author":"Varges","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/jpet.118.252064_bib51","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1182\/blood-2011-04-351643","article-title":"Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis","volume":"118","author":"Ward","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.118.252064_bib52","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1038\/bcj.2017.26","article-title":"Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis","volume":"7","author":"Wechalekar","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1124\/jpet.118.252064_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/AAC.28.2.347","article-title":"Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis","volume":"28","author":"Yim","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.252064_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.252064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:51:51Z","timestamp":1739994711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0022356524260225"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.252064","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.252064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}